Calithera Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Calithera Biosciences

11/05/2022 14:03

* Calithera Biosciences Inc  CALA.OQ  reported a quarterly
adjusted loss of 18 cents​​ per share for the quarter ended in
March. The mean expectation of four analysts for the quarter was
for a loss of 18 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Calithera Biosciences Inc's reported EPS for the quarter
was a
loss of 18 cents​.
    * The mean earnings estimate of analysts had fallen by
about 19.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Calithera Biosciences Inc shares had fallen by 49.3% this
quarter and lost 69.2% so far this year.
    * The company reported a quarterly loss of $13.84 million.
    * Wall Street's median 12-month price target for Calithera
Biosciences Inc is $1.75 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 11 at 01:02 p.m.  ​All
figures in US dollars unless otherwise stated